Arcus Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
43.42
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
8
|
|
# Buys
|
2
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.04
|
-0.90
|
0.14
|
13.46%
|
|
2022-06-30
|
-0.94
|
-0.93
|
0.01
|
1.06%
|
|
2022-03-31
|
-0.86
|
-0.96
|
-0.10
|
-11.63%
|
|
2021-12-31
|
-0.74
|
3.71
|
4.45
|
601.35%
|
|
2021-09-30
|
-1.08
|
-1.11
|
-0.03
|
-2.78%
|
|
2021-06-30
|
-0.87
|
-1.09
|
-0.22
|
-25.29%
|
|
2021-03-31
|
-0.83
|
-1.08
|
-0.25
|
-30.12%
|
|
2020-12-31
|
-0.75
|
-0.82
|
-0.07
|
-9.33%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.79
|
|
2021-12-31
|
0.43
|
|
2020-12-31
|
-2.35
|
|
2019-12-31
|
-1.94
|
|
2018-12-31
|
-2.22
|
|
2017-12-31
|
-0.55
|